Differentiated KCs have been suggested to be the primary responders to IL-17A in psoriasis on the basis of previous studies by using in vitro KC systems, given larger effect sizes in differentiated compared with monolayer KCs (Chiricozzi et al., 2014). The gene discussed is TBCE; the disease is keratoconus.